N-Benzyl-2-(piperazin-1-yl)acetamide

Catalog No. :
ACWLHR100
CAS No. :
827614-58-4
Molecular Formula :
C13H19N3O
Molecular Weight :
233.32

IUPAC Name:N-benzyl-2-(piperazin-1-yl)acetamide

N-Benzyl-2-(piperazin-1-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$81.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Benzyl-2-(piperazin-1-yl)acetamide
IUPAC NameN-benzyl-2-(piperazin-1-yl)acetamide
MDL No.MFCD08691368
Molecular FormulaC13H19N3O
Molecular Weight233.32
SMILESO=C(N)CN1CCN(CC2=CC=CC=C2)CC1
InChI KeyPEFLHMLMYGIRGW-UHFFFAOYSA-N
SynonymN-Benzyl-2-(piperazin-1-yl)acetamide dihydrochloride 97%;N-(phenylmethyl)-2-(1-piperazinyl)acetamide;N-(phenylmethyl)-2-piperazin-1-ylacetamide;N-(phenylmethyl)-2-piperazin-1-yl-acetamide;N-(phenylmethyl)-2-piperazin-1-yl-ethanamide;N-BENZYL-2-PIPERAZIN-1-YL-ACETAMIDE DIHYDROCHLORIDE;Piperazino-acetic acid-benzylamide dihydrochloride;N-Benzyl-2-(piperazin-1-yl)acetamidedihydrochloride97%
CAS No.827614-58-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWLHR100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWLHR100 route product structure diagram
    ACWLHR100827614-58-4
Inquiry

2. ACWLHR100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWLHR100 route product structure diagram
    ACWLHR100827614-58-4
Inquiry

Comments (0)